Drug Shortage Report for FUROSEMIDE INJECTION USP

Last updated on 2018-04-27 History
Report ID 34270
Drug Identification Number 02384094
Brand name FUROSEMIDE INJECTION USP
Common or Proper name FUROSEMIDE INJECTION
Company Name HIKMA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) FUROSEMIDE
Strength(s) 10MG
Dosage form(s) SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS
Packaging size 2 ML
ATC code C03CA
ATC description HIGH-CEILING DIURETICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2017-10-31
Estimated end date 2018-04-24
Actual end date 2018-04-26
Shortage status Resolved
Updated date 2018-04-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 5995 AVEBURY ROAD, SUITE 804
MISSISSAUGA, ONTARIO
CANADA L5R 3P9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v13 2018-04-27 English Compare
v12 2018-04-26 French Compare
v11 2018-04-26 English Compare
v10 2018-04-23 French Compare
v9 2018-04-23 English Compare
v8 2018-04-04 French Compare
v7 2018-04-04 English Compare
v6 2018-02-23 French Compare
v5 2018-02-23 English Compare
v4 2018-02-15 French Compare
v3 2018-02-15 English Compare
v2 2017-12-22 French Compare
v1 2017-12-22 English Compare

Showing 1 to 13 of 13